Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching and maintained long-term ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Legislation providing more scrutiny for pharmacy benefit managers (PBMs) that failed to make it through Congress in the ...

Carl Schmid, executive director of the HIV+Hepatitis Policy Institute in Washington, D.C., talks about the problems associated with generic HIV PrEP drug markups and potential ways to fix it.

For decades, red light therapy has been an adjunct treatment for numerous ailments. But it may not work for all the medical conditions that supporters say it does.

Managing Director Pakistan Bait-ul-Mal (PBM) in Peshawar, Senator Capt. Shaheen Khalid Butt said that PBM continued to ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

The Federal Trade Commission (“FTC”) released its second interim report on Jan. 14, 2025, accusing pharmacy benefit managers (PBMs) of marking up the prices of specialty generic drugs. FTC’s report ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue through ...

For both reasons, each person’s treatment plan will be different. Read on to learn about the types of MS treatments available. Disease-modifying therapies (DMTs) can reduce the frequency and ...